Quick Answer
Eloxx Pharmaceuticals, Inc. reported Total Assets of $5.27 million for fiscal year 2025.
Eloxx Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $5.27M | +77.1% |
| 2024 | $2.98M | +73.8% |
| 2023 | $1.71M | -91.9% |
| 2022 | $21.12M | -53.2% |
| 2021 | $45.14M | +70.5% |
| 2020 | $26.48M | -55.1% |
| 2019 | $58.95M | +16.2% |
| 2018 | $50.72M | +104.6% |
| 2017 | $24.78M | +324.0% |
| 2017 | $5.85M | +86.9% |
| 2016 | $3.13M | -66.1% |
| 2016 | $9.23M | -52.8% |
| 2015 | $19.55M | -41.4% |
| 2014 | $33.33M | +369.7% |
| 2013 | $7.10M | +2.1% |
| 2012 | $6.95M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $6.04M | -77.5% | +0.8% |
| June 30, 2023 | $5.99M | -81.8% | -16.8% |
| March 31, 2023 | $7.20M | -83.5% | -65.9% |
| December 31, 2022 | $21.12M | -53.2% | -21.4% |
| September 30, 2022 | $26.88M | -51.5% | -18.4% |
| June 30, 2022 | $32.94M | -45.7% | -24.5% |
| March 31, 2022 | $43.62M | +114.2% | -3.4% |
| December 31, 2021 | $45.14M | +70.5% | -18.5% |
- Eloxx Pharmaceuticals, Inc. showed an increase of +77.1% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Eloxx Pharmaceuticals, Inc.’s total assets has declined by 24.2% (from $6.95 million to $5.27 million).
- The most recent figure is from Eloxx Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: